PYXS is trading 6.7% up today at $2.62, with recent company-specific news providing a potential catalyst. - The company announced a private placement on June 30, 2026, to raise approximately $50 million (with potential for an additional $64 million from warrants), expected to close around July 2, 2026. - Alongside the financing, Pyxis Oncology also disclosed a shift in its clinical data calendar, delaying updated monotherapy data to Fall 2026 and combination data to Q4 2026. - The stock's current movement follows a period of high volatility, including a 6.5% decline on July 6, 2026.